OpenLB
Open Library of Bioscience
Advanced Search
Neuropsychiatric disease and treatment
2021;17 2369-2386.

A Case-Control Study on Behavioral Addictions and Neurocognition: Description of the BANCO and BANCO2 Protocols.

Elodie Hurel, Marie Grall-Bronnec, Elsa Thiabaud, Anaïs Saillard, Jean-Benoît Hardouin, Gaëlle Challet-Bouju
Author Information
  1. Elodie Hurel: CHU Nantes, Addictology and Psychiatry Department, Nantes, France. ORCID
  2. Marie Grall-Bronnec: CHU Nantes, Addictology and Psychiatry Department, Nantes, France.
  3. Elsa Thiabaud: CHU Nantes, Addictology and Psychiatry Department, Nantes, France.
  4. Anaïs Saillard: CHU Nantes, Addictology and Psychiatry Department, Nantes, France.
  5. Jean-Benoît Hardouin: INSERM U1246 SPHERE (methodS in Patient-centered outcomes & HEalth ResEarch), University of Nantes, University of Tours, Nantes, France.
  6. Gaëlle Challet-Bouju: CHU Nantes, Addictology and Psychiatry Department, Nantes, France.
PMID: 34321880 DOI: 10.2147/NDT.S292490

Abstract

INTRODUCTION: Only two behavioral addictions (BAs) are currently recognized in international classifications (gambling disorder: GbD; gaming disorder: GmD), while some of them await further investigation (food addiction: FA; sexual addiction: SA). Neurocognitive functioning is considered a risk factor for BAs. Research is quite abundant for GbD and highlights specific deficits in several cognitive functions. Nevertheless, grey areas still exist. The aim of this research programme is to investigate the neurocognitive profiles of patients presenting with various BAs and to establish parallels between different forms of BA to achieve a common addiction concept.
METHODS AND ANALYSIS: This research program is composed of two studies sharing the same methodology but focusing on different samples: the BANCO study aims to include 30 individuals with a GbD, whereas the BANCO2 study aims to include 30 individuals with a GmD, 30 with a SA, and 30 with a FA. Moreover, for each BA group, 30 healthy controls will be recruited, matched by sex, age and education level. Several cognitive tasks will be completed by participants. Cue reactivity and physiological responses, as well as clinical data regarding addiction characteristics and personality, will also be investigated. A composite score based on the cognitive tasks will be computed using principal component analysis (PCA). Overall cognitive performance and detailed performance on the different cognitive tasks will be compared between individuals with BAs and their matched healthy controls using linear models with random effects. Comparisons will also be made between BA groups to investigate specific alterations associated with each disorder.
DISCUSSION: The results of this research programme will impact both research and clinical areas by (i) providing new knowledge for discussions regarding the inclusion of BAs under the spectrum of addictive disorders; (ii) improving understanding of addiction mechanisms in general; (iii) providing clarity in the grey areas in neurocognitive research on BAs and improving the understanding of less studied BAs, (iv) guiding clinicians to propose therapeutic alternatives and complementary programmes.
TRIAL REGISTRATION: BANCO study (ClinicalTrials.gov NCT03202290); BANCO2 study (ClinicalTrials.gov NCT03967418).

Keywords

behavioral addiction food addiction gambling disorder gaming disorder neurocognition neuropsychology sexual addiction

Associated Data

ClinicalTrials.gov | NCT03967418; NCT03202290

References

  1. J Psychoactive Drugs. 2012 Jan-Mar;44(1):5-17 [PMID: 22641961]
  2. Drug Alcohol Depend. 2017 Dec 1;181:152-161 [PMID: 29055269]
  3. Prog Brain Res. 2016;224:323-44 [PMID: 26822365]
  4. Psychiatry Res. 2018 Jul;265:279-283 [PMID: 29772488]
  5. Brain Res Cogn Brain Res. 2005 Apr;23(1):137-51 [PMID: 15795140]
  6. Cyberpsychol Behav Soc Netw. 2015 Oct;18(10):581-7 [PMID: 26383549]
  7. Schizophr Bull. 2006 Oct;32 Suppl 1:S44-63 [PMID: 16916889]
  8. Addiction. 2003 Jan;98(1):61-70 [PMID: 12492756]
  9. Neuropsychopharmacology. 2017 Sep;42(10):2021-2031 [PMID: 28409565]
  10. PLoS One. 2012;7(3):e30909 [PMID: 22479305]
  11. PLoS One. 2014 Jul 11;9(7):e102419 [PMID: 25013940]
  12. Nutrients. 2014 Sep 16;6(9):3653-71 [PMID: 25230209]
  13. Neurosci Biobehav Rev. 2019 Nov;106:227-233 [PMID: 30359663]
  14. Addict Behav. 2017 Aug;71:54-60 [PMID: 28264786]
  15. Addiction. 2016 Dec;111(12):2097-2106 [PMID: 26893127]
  16. Appetite. 2017 Apr 1;111:79-85 [PMID: 28042040]
  17. CNS Spectr. 2014 Dec;19(6):486-95 [PMID: 24589040]
  18. Psychopathology. 1996;29(2):139-44 [PMID: 8861519]
  19. Lancet Psychiatry. 2017 Sep;4(9):663-664 [PMID: 28853408]
  20. Clin Neuropsychol. 2012;26(7):1142-53 [PMID: 22928670]
  21. Int Rev Neurobiol. 2016;129:67-83 [PMID: 27503448]
  22. Drug Alcohol Depend. 2006 Feb 28;81(3):251-7 [PMID: 16095852]
  23. Drug Alcohol Depend. 2012 Nov 1;126(1-2):1-6 [PMID: 22475814]
  24. Addict Behav. 2008 Apr;33(4):515-27 [PMID: 18054174]
  25. J Sex Med. 2011 Aug;8(8):2227-36 [PMID: 21595837]
  26. Assessment. 2003 Sep;10(3):228-36 [PMID: 14503646]
  27. Appetite. 2007 Nov;49(3):687-90 [PMID: 17719677]
  28. J Dual Diagn. 2016;12(1):83-9 [PMID: 26828571]
  29. Front Psychiatry. 2019 Mar 22;10:136 [PMID: 30984037]
  30. Front Psychiatry. 2018 Aug 31;9:406 [PMID: 30233427]
  31. Indian J Psychol Med. 2013 Apr;35(2):180-9 [PMID: 24049230]
  32. Br J Addict. 1990 Nov;85(11):1403-8 [PMID: 2285834]
  33. Behav Cogn Neurosci Rev. 2004 Dec;3(4):243-60 [PMID: 15812109]
  34. Schizophr Bull. 2008 Nov;34(6):1211-20 [PMID: 18184635]
  35. Eur Eat Disord Rev. 2016 Nov;24(6):482-488 [PMID: 27593963]
  36. J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):411-6 [PMID: 22291219]
  37. Clin Psychol Rev. 2020 Dec;82:101925 [PMID: 33038740]
  38. Drug Alcohol Depend. 2008 Jul 1;96(1-2):111-20 [PMID: 18378098]
  39. Psychiatry Res. 2008 Mar 15;158(2):155-63 [PMID: 18215765]
  40. Front Biosci (Landmark Ed). 2018 Jan 1;23:811-836 [PMID: 28930574]
  41. Curr Opin Gastroenterol. 2010 Mar;26(2):165-9 [PMID: 20042860]
  42. J Behav Addict. 2019 Jun 1;8(2):223-233 [PMID: 31120316]
  43. Chronic Dis Transl Med. 2016 Dec 20;2(4):235-240 [PMID: 29063048]
  44. PLoS One. 2018 Sep 13;13(9):e0204151 [PMID: 30212574]
  45. Neurosci Biobehav Rev. 2019 Sep;104:1-10 [PMID: 31247240]
  46. Arch Clin Neuropsychol. 2007 Feb;22(2):151-60 [PMID: 17207962]
  47. Psychol Med. 2005 Feb;35(2):245-56 [PMID: 15841682]
  48. J Affect Disord. 2013 May;147(1-3):171-9 [PMID: 23218249]
  49. J Clin Exp Neuropsychol. 2014;36(2):144-57 [PMID: 24479640]
  50. Psychiatry Res. 2016 Feb 28;236:125-129 [PMID: 26730447]
  51. J Int Neuropsychol Soc. 2014 May;20(5):547-54 [PMID: 24867441]
  52. Nat Protoc. 2006;1(5):2277-81 [PMID: 17406468]
  53. Neuropharmacology. 2011 Dec;61(7):1109-22 [PMID: 21459101]
  54. PLoS One. 2014 Aug 25;9(8):e105476 [PMID: 25153083]
  55. Eur Eat Disord Rev. 2014 Nov;22(6):389-96 [PMID: 25139680]
  56. Expert Opin Pharmacother. 2020 Feb;21(3):287-296 [PMID: 31928246]
  57. Cogn Psychol. 2000 Aug;41(1):49-100 [PMID: 10945922]
  58. Riv Psichiatr. 2016 Mar-Apr;51(2):60-5 [PMID: 27183510]
  59. Ann Clin Psychiatry. 2010 Feb;22(1):56-62 [PMID: 20196983]
  60. World Psychiatry. 2018 Feb;17(1):109-110 [PMID: 29352554]
  61. Front Psychol. 2017 Jun 23;8:1059 [PMID: 28690578]
  62. Nutrients. 2018 Apr 12;10(4): [PMID: 29649120]
  63. Addiction. 2016 Dec;111(12):2107-2108 [PMID: 26936832]
  64. Psychon Bull Rev. 2017 Dec;24(6):1686-1717 [PMID: 28092078]
  65. Int Rev Neurobiol. 2016;129:85-110 [PMID: 27503449]
  66. J Addict Med. 2014 Nov-Dec;8(6):450-61 [PMID: 25303984]
  67. Drug Alcohol Depend. 2015 Mar 1;148:118-25 [PMID: 25630963]
  68. Neuroimage. 2008 Jun;41(2):636-47 [PMID: 18413289]
  69. Front Psychiatry. 2019 Nov 08;10:824 [PMID: 31780973]
  70. Obes Facts. 2016;9(5):299-309 [PMID: 27701173]
  71. Front Syst Neurosci. 2015 Mar 10;9:24 [PMID: 25805975]
  72. Am J Psychiatry. 1993 Jun;150(6):885-90 [PMID: 8494063]
  73. Arch Gen Psychiatry. 2011 Aug;68(8):808-16 [PMID: 21464344]
  74. Acta Psychiatr Scand. 1983 Jun;67(6):361-70 [PMID: 6880820]
  75. Arch Gen Psychiatry. 1993 Dec;50(12):975-90 [PMID: 8250684]
  76. Lancet. 2001 Feb 3;357(9253):354-7 [PMID: 11210998]
  77. Neurosci Biobehav Rev. 2016 Dec;71:252-266 [PMID: 27590829]
  78. Encephale. 1995 Mar-Apr;21(2):117-22 [PMID: 7781582]
  79. Encephale. 2020 Oct;46(5):334-339 [PMID: 32151449]
  80. Behav Res Methods. 2008 May;40(2):563-74 [PMID: 18522068]
  81. Medicine (Baltimore). 2016 Dec;95(50):e5695 [PMID: 27977620]
  82. Drug Alcohol Depend. 2015 Nov 1;156:38-46 [PMID: 26404954]
  83. J Behav Ther Exp Psychiatry. 2017 Mar;54:204-210 [PMID: 27592413]
  84. Curr Opin Neurobiol. 2001 Apr;11(2):231-9 [PMID: 11301245]
  85. Cognition. 1994 Apr-Jun;50(1-3):7-15 [PMID: 8039375]
  86. Nat Neurosci. 2005 Nov;8(11):1458-63 [PMID: 16251988]
  87. Psychiatry Res. 2009 Nov 30;174(2):146-51 [PMID: 19836930]
  88. Addict Behav. 2004 Nov;29(8):1685-90 [PMID: 15451138]
  89. BMJ. 2013 Jan 08;346:e7586 [PMID: 23303884]
  90. Addict Behav. 2015 May;44:9-15 [PMID: 25182375]
  91. Drug Alcohol Depend. 2013 Oct 1;132(3):587-96 [PMID: 23660242]
  92. Nutr Hosp. 2017 Nov 17;34(5):1448-1454 [PMID: 29280663]
  93. J Subst Abuse Treat. 2014 Jul;47(1):58-72 [PMID: 24629886]
  94. J Behav Addict. 2015 Mar;4(1):14-21 [PMID: 25786495]
  95. Neuropsychol Rehabil. 2018 Sep;28(6):1019-1027 [PMID: 27624393]
  96. Neuropsychol Rev. 2019 Mar;29(1):27-51 [PMID: 30293096]
  97. Front Psychol. 2017 Dec 04;8:1961 [PMID: 29255433]
  98. Encephale. 2010 Oct;36(5):380-9 [PMID: 21035628]
  99. Can J Psychiatry. 2017 Mar;62(3):199-210 [PMID: 28212499]
  100. Cortex. 1976 Dec;12(4):313-24 [PMID: 1009768]
  101. Am J Drug Alcohol Abuse. 2010 Sep;36(5):254-60 [PMID: 20666699]
  102. Nutrients. 2018 Dec 28;11(1): [PMID: 30597858]
  103. Eur Eat Disord Rev. 2016 Nov;24(6):518-522 [PMID: 27578243]
  104. Ann Intern Med. 2013 Feb 5;158(3):200-7 [PMID: 23295957]
  105. Eur Addict Res. 2017;23(4):204-210 [PMID: 28877518]
  106. J Child Psychol Psychiatry. 2001 May;42(4):551-6 [PMID: 11383971]
  107. Addict Behav. 2018 Apr;79:171-177 [PMID: 29291508]
  108. Curr Dir Psychol Sci. 2012 Feb;21(1):8-14 [PMID: 22773897]
  109. Acta Neurol Belg. 1990;90(4):207-17 [PMID: 2124031]
  110. Neurosci Biobehav Rev. 2014 Nov;47:295-306 [PMID: 25205078]
  111. Encephale. 2005 Jan-Feb;31(1 Pt 1):31-43 [PMID: 15971638]
  112. Appetite. 2017 Aug 1;115:9-15 [PMID: 27984189]
  113. Front Psychiatry. 2017 Dec 14;8:285 [PMID: 29312016]
  114. Int J Mol Sci. 2020 Apr 24;21(8): [PMID: 32344532]
  115. Appetite. 2009 Apr;52(2):430-6 [PMID: 19121351]
  116. Annu Rev Clin Psychol. 2018 May 7;14:399-423 [PMID: 29734827]
  117. Neuropsychologia. 1993 Jan;31(1):17-28 [PMID: 8437679]
  118. Biochem Pharmacol. 2008 Jan 1;75(1):266-322 [PMID: 17764663]
  119. Curr Opin Neurobiol. 2013 Aug;23(4):632-8 [PMID: 23395462]
  120. Eur Eat Disord Rev. 2018 Nov;26(6):574-584 [PMID: 30159982]
  121. J Behav Addict. 2014 Dec;3(4):246-53 [PMID: 25592310]
  122. J Psychiatr Res. 2016 Feb;73:1-8 [PMID: 26656573]
  123. J Gambl Stud. 2017 Dec;33(4):1213-1239 [PMID: 28255940]
  124. Percept Mot Skills. 1997 Dec;85(3 Pt 1):1018 [PMID: 9399312]
  125. Yale J Biol Med. 2015 Sep 03;88(3):295-302 [PMID: 26339213]
  126. Psychol Res. 2009 May;73(3):364-71 [PMID: 18636272]
  127. J Gambl Stud. 2013 Sep;29(3):359-75 [PMID: 22644097]
  128. Neuropsychopharmacology. 2019 Jul;44(8):1354-1361 [PMID: 30986818]
  129. CNS Drugs. 2016 Aug;30(8):719-33 [PMID: 27401883]
  130. Psychosom Med. 2014 Nov-Dec;76(9):694-700 [PMID: 25393125]
Journal Article

Word Cloud

Created with Highcharts 10.0.0BAswilladdictioncognitiveresearch30studyGbDareasdifferentBABANCOindividualsBANCO2tasksdisordertwobehavioralgamblingdisorder:gamingGmDfoodaddiction:FAsexualSAspecificgreyprogrammeinvestigateneurocognitiveaimsincludehealthycontrolsmatchedclinicalregardingalsousingperformanceprovidingimprovingunderstandingClinicalTrialsgovINTRODUCTION:addictionscurrentlyrecognizedinternationalclassificationsawaitinvestigationNeurocognitivefunctioningconsideredriskfactorResearchquiteabundanthighlightsdeficitsseveralfunctionsNeverthelessstillexistaimprofilespatientspresentingvariousestablishparallelsformsachievecommonconceptMETHODSANDANALYSIS:programcomposedstudiessharingmethodologyfocusingsamples:whereasMoreovergrouprecruitedsexageeducationlevelSeveralcompletedparticipantsCuereactivityphysiologicalresponseswelldatacharacteristicspersonalityinvestigatedcompositescorebasedcomputedprincipalcomponentanalysisPCAOveralldetailedcomparedlinearmodelsrandomeffectsComparisonsmadegroupsalterationsassociatedDISCUSSION:resultsimpactnewknowledgediscussionsinclusionspectrumaddictivedisordersiimechanismsgeneraliiiclaritylessstudiedivguidingcliniciansproposetherapeuticalternativescomplementaryprogrammesTRIALREGISTRATION:NCT03202290NCT03967418Case-ControlStudyBehavioralAddictionsNeurocognition:DescriptionProtocolsneurocognitionneuropsychology

Similar Articles

Cited By